Leading provider of FDA cleared AI-software for precision medical-imaging
Quantib company profile
Quantib offers Artificial-Intelligence software that improves the readability of MRI images. The software addresses 3 needs: brain-imaging, prostate-imaging, and breast-imaging.
Correct interpretation of MRI-images is complex, technical, and requires radiologists to have years of specialized experience. The learning-curve to correctly diagnose MRI-images is slow. Furthermore, it is important that radiologists are able to correctly interpret medical images involving neurodegenerative diseases, prostate-cancer, and breast-cancer.
Spun-off from the Erasmus MC, Quantib’s software has been developed by a thought-leading team of scientists with over 25 years of relevant experience. The Company has strategic sales-distribution partnerships with blue-chip medical-hardware distributors. Quantib has R&D partnerships with the largest Dutch academic-hospitals.
Investment: 2019
| Dennendonck investment criteria | |
|---|---|
| Improved patient experience | ✓ |
| Healthcare cost containment | ✓ |
| Consolidation of healthcare services | |
| Scalable, low-Capex business model | ✓ |
| Dennendonck value creation | |
|---|---|
| Board membership | ✓ (Chairman) |
| Strategic positioning | ✓ |
| Sales growth | ✓ |
| Internationalization via network | ✓ |
| Operational improvement | ✓ |
| Buy & Build |
Maak jouw eigen website met JouwWeb